{ "items": [ "\n\n
\n \n 3 February 2023\n \n
\n\n \n \n \n\n \n \n \nBelow is a transcript of an address from the Chancellor of the University of Oxford, Lord Patten of Barnes, at the Admission Ceremony of the University's 273rd Vice-Chancellor Professor Irene Tracey CBE, FMedSci. on Tuesday 10 January, 2023.
\n \n\n\n \n 3 February 2023\n \n
\n\n \n \n \n\n \n \n \nNearly one in 10 young people are experiencing both persistent physical pain and suicidal feelings, according to a new paper from researchers from the University of Oxford, Cambridge, Oslo (Norway), King\u2019s College London, and the Parc Sanitari Sant Joan de Deu (Spain).
\n \n\n\n \n 3 February 2023\n \n
\n\n \n \n \n\n \n \n \nThe Academic Futures programme, which aims to address under-representation and help improve equality, diversity and inclusion in Oxford\u2019s graduate student body through scholarships, is expanding.
\n \n\n\n \n 3 February 2023\n \n
\n\n \n \n \n\n \n \n \nMore than 40,000 doses of Oxford\u2019s Ebola vaccine have been manufactured by SII (Serum Institute of India) in just 60 days and doses shipped to Uganda.
\n \n\n\n \n 1 February 2023\n \n
\n\n \n \n \n\n \n \n \nA vaccine scientist from the University of Oxford recently received the prestigious Presidential Distinguished Service Award for the Irish Abroad for 2022, which recognises the contribution of members of the Irish diaspora.
\n \n\n\n \n 1 February 2023\n \n
\n\n \n \n \n\n \n \n \nA Tik-Tok-style short video app, specifically for marginalised groups in low-income countries, has been developed and trialled by researchers at Oxford and the University of Birmingham. It has proved highly successful. Use of the app had a positive effect on entrepreneurship and employment \u2013 enabling participants to deal better with the impact of the COVID-19 pandemic.
\n \n\n\n \n 5 December 2022\n \n
\n\n \n \n \n\n \n \n \nSmoking increases the risks of 56 diseases and kills more than one million adults in China each year from 22 different causes, according to new research published in The Lancet Public Health.
\n \n\n\n \n 5 December 2022\n \n
\n\n \n \n \n\n \n \n \nIn this long read published to coincide with International AIDS Day, we explore how an international collaboration \u2013 of which the University of Oxford is a key partner \u2013 has boosted HIV vaccine research. We thank our partners at Imperial College London for allowing us to reproduce and abridge this article.
\n \n\n\n \n 22 November 2022\n \n
\n\n \n \n \n\n \n \n \nA new study published by University of Oxford researchers in an open-access journal, JMIR Pediatrics and Parenting, shows that although many school-age adolescents are spending considerable time gaming, it is not having a negative impact on their wellbeing.
\n \n\n\n \n 22 November 2022\n \n
\n\n \n \n \n\n \n \n \nA new Oxford University study released during World Antimicrobial Awareness Week has significant findings on how antimicrobial resistance (AMR) arises and persists. The results, published today in Nature Communications, provide the first direct evidence of AMR bacteria migrating from a patient\u2019s gut microbiome to the lungs, increasing the risk of deadly infections.
\n \n\n\n \n 18 November 2022\n \n
\n\n \n \n \n\n \n \n \nA vaccine developed by the Oxford Vaccine Group\u2019s Prof Teresa Lambe and supported in clinical trials and manufacture scale-up by researchers from the Jenner Institute (Nuffield Department of Medicine) has been recommended for inclusion in a ring vaccination trial to combat a Sudan ebolavirus outbreak in Uganda.
\n \n\n\n \n 18 November 2022\n \n
\n\n \n \n \n\n \n \n \nThe latest Cochrane Review finds high certainty evidence that nicotine e-cigarettes are more effective than traditional nicotine-replacement therapy (NRT) in helping people quit smoking.
\n \n\n\n \n 17 November 2022\n \n
\n\n \n \n \n\n \n \n \nScientists from Oxford University and the University of Birmingham have made the first bone marrow \u2018organoids\u2019 that include all the key components of human marrow. This technology allows for the screening of multiple anti-cancer drugs at the same time, as well as testing personalised treatments for individual cancer patients.
\n \n\n\n \n 17 November 2022\n \n
\n\n \n \n \n\n \n \n \nOxford Research reveals high blood glucose reprograms the metabolism of pancreatic beta-cells in diabetes.
\n \n\n\n \n 17 November 2022\n \n
\n\n \n \n \n\n \n \n \nMore sociable monkeys have a higher abundance of certain beneficial gut bacteria, and a lower abundance of potentially disease-causing bacteria, new research has found.
\n \n\n\n \n 10 November 2022\n \n
\n\n \n \n \n\n \n \n \nResearchers, led by the Nuffield Department of Primary Care Health Sciences, University of Oxford, have developed a new tool for doctors to identify patients at high risk of serious falls. The tool could have a big impact on the way older patients are managed in primary care, improving targeting of drug treatment and fall prevention strategies for high-risk individuals.
\n \n\n\n \n 10 November 2022\n \n
\n\n \n \n \n\n \n \n \nThe University of Oxford has led the largest and most comprehensive analysis of the entire genomic landscape of the commonest type of blood cancer called chronic lymphocytic leukaemia (CLL) as part of the UK\u2019s 100,000 Genomes Project. This work defines five genomic subgroups of CLL and associates these with clinical outcomes, and these subgroups provide a better estimation of patient prognosis than achieved by previous single gene analyses, allowing more tailored patient care.
\n \n\n\n \n 10 November 2022\n \n
\n\n \n \n \n\n \n \n \nResearchers from the University of Oxford have today reported findings from a study that investigated whether previously identified correlates of protection associated with risk of full-blown tuberculosis (TB) disease could also be associated with risk of infection from the bacteria that causes TB - highlighting certain correlates in the process.
\n \n\n\n \n 10 November 2022\n \n
\n\n \n \n \n\n \n \n \nA phase I/IIa clinical trial that the University of Oxford collaborated on has demonstrated that a T-cell therapeutic HIV vaccine was associated with better control of the virus rebound when antiretroviral therapy (ART) was temporarily withdrawn.
\n \n\n\n \n 10 November 2022\n \n
\n\n \n \n \n\n \n \n \nA new study published in the journal Science Advances sheds light on how Gram-negative bacteria like E. coli construct their outer membrane to resemble body armour, which has far-reaching implications for the development of antibiotics.
\n \n\n